ALNYLAM PHARMACEUTICALS, INC.: operating_income

Value{"amount": -500088000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Period2017-01-01 – 2017-12-31
Statuscurrent
EntityALNYLAM PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-18-002152
Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001178670/operating-income/2017-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/3e141041-a2db-448f-a2cb-3a074c9c7b0e

History